RECRUITING

Metabolism Evaluation Through Resting Indirect Calorimetry in Bladder Cancer (METRICS)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study is being done to learn more about energy needs and muscle function during treatment for bladder cancer. These insights can help improve future patient care. The study team found in a previous study that resting energy can be different than what estimates show. Patients with bladder cancer are known to suffer a decline in physical resilience over time. Monitoring patients to understand these changes better could help design future treatments with these vulnerabilities in mind.

Official Title

METRICS Study: Metabolic Evaluation Through Resting Indirect Calorimetry in Bladder Cancer

Quick Facts

Study Start:2025-01-21
Study Completion:2026-06
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06721260

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Confirmed cancer diagnosis
  2. * Scheduled for platinum-based chemotherapy followed by radical cystectomy
  3. * Adequate renal and cardiac function for platinum-based chemotherapy
  1. * Prior chemotherapy or radiotherapy for bladder cancer
  2. * Severe cardiac, renal, hepatic, respiratory or metabolic diseases
  3. * Pregnant or breastfeeding
  4. * Uncontrolled conditions that could affect study outcomes

Contacts and Locations

Study Contact

Jill M. Hamilton-Reeves, PhD, RD, CSO
CONTACT
913-588-7650
jhamilton-reeves@kumc.edu
Misty D Bechtel, BA, CCRP
CONTACT
913-945-5037
mbechtel2@kumc.edu

Principal Investigator

Jill M Hamilton-Reeves, PhD, RD, CSO
PRINCIPAL_INVESTIGATOR
University of Kansas Medical Center

Study Locations (Sites)

University of Kansas Medical Center
Kansas City, Kansas, 66160
United States
University of Kansas Medical Center
Kansas City, Kansas, 66160
United States

Collaborators and Investigators

Sponsor: University of Kansas Medical Center

  • Jill M Hamilton-Reeves, PhD, RD, CSO, PRINCIPAL_INVESTIGATOR, University of Kansas Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-01-21
Study Completion Date2026-06

Study Record Updates

Study Start Date2025-01-21
Study Completion Date2026-06

Terms related to this study

Keywords Provided by Researchers

  • Bladder cancer
  • resting energy expenditure
  • cachexia
  • growth differentiation factor 15 (GDF-15)
  • Nutrition status
  • radical cystectomy
  • neoadjuvant chemotherapy
  • body composition

Additional Relevant MeSH Terms

  • Bladder Cancer